Malignant Pleural Mesothelioma: A Comprehensive Review
Journal of Clinical Medicine · 30.09.2024 · 13 (19) · 5837
DOI: 10.3390/jcm13195837 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.09.2024. Verfasst von Molly Jain und 3 weiteren Autor:innen. Beteiligte Einrichtung: Parkview Health, Fort Wayne, IN 46845, USA. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mesotheliomas are hyperplastic tumors that envelop the serosal membranes that safeguard the body’s external surfaces. Although certain instances may exhibit indolent characteristics, a significant number of tumors demonstrate rapid progression and a poor prognosis. Mesotheliomas are typically categorized as benign or malignant, with malignant mesothelioma being more frequently linked to asbestos exposure. Malignant pleural mesothelioma (MPM) predominantly impacts males and often emerges in the late 50 s or beyond, characterized by a median age of early 70 s among patients exposed to asbestos lasting from 2 to 4 decades. Respiratory exposure to asbestos particles leads to the development of malignant mesothelioma, characterized by recurrent inflammation, disruption of cell division, activation of proto-oncogenes, and generation of free radicals. In pleural mesothelioma, BAP1, CDKN2A, and NF are the most often mutated genes. Accurate diagnosis and assessment usually require the use of chest computed tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET). Radiation therapy, immunotherapy, chemotherapy, and surgery are some of the treatment options that are currently available. This systematic review provides a comprehensive analysis of the latest research, biomarkers, evaluation, and management strategies for malignant pleural mesothelioma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Parkview Health, Fort Wayne, IN 46845, USA.
ORCID-Profile: Molly Jain
Zitieren
APA
Jain, M., Crites, M. K., Rich, P., & Bajantri, B. (2024). Malignant Pleural Mesothelioma: A Comprehensive Review. Journal of Clinical Medicine, 13(19), 5837. https://doi.org/10.3390/jcm13195837
Vancouver
Jain M, Crites MK, Rich P, Bajantri B. Malignant Pleural Mesothelioma: A Comprehensive Review. Journal of Clinical Medicine. 2024;13(19):5837. doi:10.3390/jcm13195837
BibTeX
@article{Jain2024,
author = {Jain, Molly and Crites, Morgan Kay and Rich, Patricia and Bajantri, Bharat},
title = {Malignant Pleural Mesothelioma: A Comprehensive Review},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {19},
pages = {5837},
doi = {10.3390/jcm13195837}
}
EUVIMED